Health-related quality of life, psychosocial outcome and neurocognitive function in metastatic cancer survivors treated with immunotherapy, followed by integrative neurocognitive remediation therapy Vrije Universiteit Brussel
led to a growing population of long-term metastatic cancer survivors.
For the first time in history, patients with metastatic disease become
and remain disease-free and this after stopping treatment. To date
not much is known about health-related quality of life (HRQOL),
psychosocial outcome and neurocognitive function in this new patient
...